Experienced meditators show greater forward travelling cortical alpha wave strengths

Bailey, N. W.; Hill, A. T.; Godfrey, K.; Perera, M. P. N.; Hohwy, J.; Corcoran, A. W.; Rogasch, N. C.; Fitzgibbon, B. M.; Fitzgerald, P. B.

doi:10.1101/2024.06.09.598110

bioRxiv · 10.1101/2024.06.09.598110

Experienced meditators show greater forward travelling cortical alpha wave strengths

Bailey, N. W.·Hill, A. T.·Godfrey, K.·Perera, M. P. N.·Hohwy, J.·Corcoran, A. W.·Rogasch, N. C.·Fitzgibbon, B. M.·Fitzgerald, P. B.

View original source ↗Export metadata ↓

Abstract

Mindfulness meditation involves training attention, commonly towards the current sensory experience, with an attitude of non-judgemental awareness. Theoretical perspectives suggest meditation alters the brains predictive processing mechanisms, increasing the synaptic gain and precision with which sensory information is processed, and reducing the generation or elaboration of higher-order beliefs. Recent research suggests that forwards and backwards travelling cortical alpha waves provide an indication of these predictive processing functions. Here, we used electroencephalography (EEG) to test whether the strength of forwards and backwards travelling cortical alpha waves differed between experienced meditators and a matched sample of non-meditators, both during an eyes-closed resting state (N = 97) and during a visual cognitive (Go/No-go) task (N = 126). Our results showed that meditators produced stronger forwards travelling cortical alpha waves compared to non-meditators, both while resting with their eyes closed and during task performance. Meditators also exhibited weaker backwards travelling cortical alpha wave strength while resting with their eyes closed. These results may be indicative of a neural mechanism underpinning enhanced attention associated with meditation practice, as well as a potential neural marker of the reductions in resting mind-wandering that are suggested to be associated with meditation practice. The results also support models of brain function that suggest attention modification can be achieved by mental training aimed at increased processing of sensory information, which might be indexed by greater strength of forwards travelling cortical alpha waves.

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Bailey, N. W., Hill, A. T., Godfrey, K., Perera, M. P. N., Hohwy, J., Corcoran, A. W., Rogasch, N. C., Fitzgibbon, B. M., Fitzgerald, P. B.. 2024-06-09. Experienced meditators show greater forward travelling cortical alpha wave strengths. https://doi.org/10.1101/2024.06.09.598110

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗